Follow-up and salvage therapy for recurrent hepatocellular carcinoma

Kelly M. McMasters; Jean Nicolas Vauthey

doi:10.1007/978-1-60327-522-4_24

Follow-up and salvage therapy for recurrent hepatocellular carcinoma

Kelly M. McMasters, Jean Nicolas Vauthey

Surgical Oncology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Although liver transplantation has become a viable option for treatment of many patients with hepatocellular carcinoma (HCC), the limited availability of donor organs and the strict criteria for organ transplantation limit the use of transplantation for this disease. Hepatic resection remains the gold standard nontransplant treatment modality and is still the first-line treatment in many centers.

Original language	English (US)
Title of host publication	Hepatocellular Carcinoma
Subtitle of host publication	Targeted Therapy and Multidisciplinary Care
Publisher	Springer New York
Pages	383-391
Number of pages	9
ISBN (Print)	9781603275217
DOIs	https://doi.org/10.1007/978-1-60327-522-4_24
State	Published - 2011

Keywords

HCC
HCC Recurrence
Hepatic resection
Molecular markers
Salvage therapy HCC

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-60327-522-4_24

Cite this

@inbook{03b518673df9460e8bf43526879ecb42,

title = "Follow-up and salvage therapy for recurrent hepatocellular carcinoma",

abstract = "Although liver transplantation has become a viable option for treatment of many patients with hepatocellular carcinoma (HCC), the limited availability of donor organs and the strict criteria for organ transplantation limit the use of transplantation for this disease. Hepatic resection remains the gold standard nontransplant treatment modality and is still the first-line treatment in many centers.",

keywords = "HCC, HCC Recurrence, Hepatic resection, Molecular markers, Salvage therapy HCC",

author = "McMasters, {Kelly M.} and Vauthey, {Jean Nicolas}",

year = "2011",

doi = "10.1007/978-1-60327-522-4_24",

language = "English (US)",

isbn = "9781603275217",

pages = "383--391",

booktitle = "Hepatocellular Carcinoma",

publisher = "Springer New York",

}

TY - CHAP

T1 - Follow-up and salvage therapy for recurrent hepatocellular carcinoma

AU - McMasters, Kelly M.

AU - Vauthey, Jean Nicolas

PY - 2011

Y1 - 2011

N2 - Although liver transplantation has become a viable option for treatment of many patients with hepatocellular carcinoma (HCC), the limited availability of donor organs and the strict criteria for organ transplantation limit the use of transplantation for this disease. Hepatic resection remains the gold standard nontransplant treatment modality and is still the first-line treatment in many centers.

AB - Although liver transplantation has become a viable option for treatment of many patients with hepatocellular carcinoma (HCC), the limited availability of donor organs and the strict criteria for organ transplantation limit the use of transplantation for this disease. Hepatic resection remains the gold standard nontransplant treatment modality and is still the first-line treatment in many centers.

KW - HCC

KW - HCC Recurrence

KW - Hepatic resection

KW - Molecular markers

KW - Salvage therapy HCC

UR - http://www.scopus.com/inward/record.url?scp=84889968894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889968894&partnerID=8YFLogxK

U2 - 10.1007/978-1-60327-522-4_24

DO - 10.1007/978-1-60327-522-4_24

M3 - Chapter

AN - SCOPUS:84889968894

SN - 9781603275217

SP - 383

EP - 391

BT - Hepatocellular Carcinoma

PB - Springer New York

ER -

Follow-up and salvage therapy for recurrent hepatocellular carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this